Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1978 1
1987 1
1988 1
1989 1
1990 4
1992 1
2004 1
2007 1
2008 2
2009 3
2010 1
2011 2
2014 2
2016 1
2017 3
2019 4
2020 2
2021 4
2022 2
2023 2
2024 5
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model.
Bianchi E, Rontauroli S, Tavernari L, Mirabile M, Pedrazzi F, Genovese E, Sartini S, Dall'Ora M, Grisendi G, Fabbiani L, Maccaferri M, Carretta C, Parenti S, Fantini S, Bartalucci N, Calabresi L, Balliu M, Guglielmelli P, Potenza L, Tagliafico E, Losi L, Dominici M, Luppi M, Vannucchi AM, Manfredini R. Bianchi E, et al. Among authors: mirabile m. Leukemia. 2023 May;37(5):1068-1079. doi: 10.1038/s41375-023-01867-3. Epub 2023 Mar 16. Leukemia. 2023. PMID: 36928007 Free PMC article.
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms.
Carretta C, Parenti S, Bertesi M, Rontauroli S, Badii F, Tavernari L, Genovese E, Malerba M, Papa E, Sperduti S, Enzo E, Mirabile M, Pedrazzi F, Neroni A, Tombari C, Mora B, Maffioli M, Mondini M, Brociner M, Maccaferri M, Tenedini E, Martinelli S, Bartalucci N, Bianchi E, Casarini L, Potenza L, Luppi M, Tagliafico E, Guglielmelli P, Simoni M, Passamonti F, Norfo R, Vannucchi AM, Manfredini R; MYNERVA (Myeloid NEoplasms Research Venture AIRC). Carretta C, et al. Among authors: mirabile m. Leukemia. 2024 Oct;38(10):2171-2182. doi: 10.1038/s41375-024-02373-w. Epub 2024 Aug 23. Leukemia. 2024. PMID: 39179669 Free PMC article.
Targeting exhausted cytotoxic T cells through CTLA-4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts.
Tavernari L, Rontauroli S, Norfo R, Mirabile M, Maccaferri M, Mora B, Genovese E, Parenti S, Carretta C, Bianchi E, Bertesi M, Pedrazzi F, Tenedini E, Martinelli S, Bochicchio MT, Guglielmelli P, Potenza L, Lucchesi A, Passamonti F, Tagliafico E, Luppi M, Vannucchi AM, Manfredini R; MYNERVA (Myeloid NEoplasms Research Venture AIRC) investigators. Tavernari L, et al. Among authors: mirabile m. Am J Hematol. 2024 Oct;99(10):1939-1950. doi: 10.1002/ajh.27428. Epub 2024 Jul 2. Am J Hematol. 2024. PMID: 38953347 Free article.
Cyber-Creativity: A Decalogue of Research Challenges.
Corazza GE, Agnoli S, Jorge Artigau A, Beghetto RA, Bonnardel N, Coletto I, Faiella A, Gerardini K, Gilhooly K, Glăveanu VP, Hanson MH, Kapoor H, Kaufman JC, Kenett YN, Kharkhurin AV, Luchini S, Mangion M, Mirabile M, Obialo FK, Phelps C, Reiter-Palmon R, Puryear JS, Sarcinella ED, Tang M, Vavassori GM, Vinchon F, Viskontas I, Weiss S, Zbainos D, Lubart T. Corazza GE, et al. Among authors: mirabile m. J Intell. 2025 Aug 13;13(8):103. doi: 10.3390/jintelligence13080103. J Intell. 2025. PMID: 40863200 Free PMC article.
CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis.
Mirabile M, Tombari C, Neroni A, Tavernari L, Norfo R, Bianchi E, Maccaferri M, Mora B, Parenti S, Carretta C, Bertesi M, Malerba M, Papa E, Fabbiani L, Bartalucci N, Guglielmelli P, Potenza L, Losi L, Passamonti F, Tagliafico E, Luppi M, Rontauroli S, Vannucchi AM, Manfredini R; MYNERVA (Myeloid NEoplasms Research Venture AIRC) investigators. Mirabile M, et al. J Cell Mol Med. 2025 Jul;29(14):e70720. doi: 10.1111/jcmm.70720. J Cell Mol Med. 2025. PMID: 40690545 Free PMC article.
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants.
Cicconi L, Testi AM, Montesinos P, Rego E, Zhu HH, Takahashi H, Dworzak M, Estey E, Schwarer A, Esteve J, Annibali O, Castelli R, Mirabile M, Angelini M, Lazarevic V, Kumar J, Avvisati G, Gurnari C, Locatelli F, Voso MT, Sanz MA, Lo-Coco F, Abla O. Cicconi L, et al. Among authors: mirabile m. Blood Cancer J. 2021 Oct 16;11(10):167. doi: 10.1038/s41408-021-00561-w. Blood Cancer J. 2021. PMID: 34657125 Free PMC article. No abstract available.
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis.
Rontauroli S, Castellano S, Guglielmelli P, Zini R, Bianchi E, Genovese E, Carretta C, Parenti S, Fantini S, Mallia S, Tavernari L, Sartini S, Mirabile M, Mannarelli C, Gesullo F, Pacilli A, Pietra D, Rumi E, Salmoiraghi S, Mora B, Villani L, Grilli A, Rosti V, Barosi G, Passamonti F, Rambaldi A, Malcovati L, Cazzola M, Bicciato S, Tagliafico E, Vannucchi AM, Manfredini R. Rontauroli S, et al. Among authors: mirabile m. Blood Adv. 2021 Mar 9;5(5):1452-1462. doi: 10.1182/bloodadvances.2020003614. Blood Adv. 2021. PMID: 33666652 Free PMC article.
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis.
Genovese E, Mirabile M, Rontauroli S, Sartini S, Fantini S, Tavernari L, Maccaferri M, Guglielmelli P, Bianchi E, Parenti S, Carretta C, Mallia S, Castellano S, Colasante C, Balliu M, Bartalucci N, Palmieri R, Ottone T, Mora B, Potenza L, Passamonti F, Voso MT, Luppi M, Vannucchi AM, Tagliafico E, Manfredini R, On Behalf Of The Mynerva MYeloid NEoplasms Research Venture Airc. Genovese E, et al. Among authors: mirabile m. Antioxidants (Basel). 2022 Jan 5;11(1):113. doi: 10.3390/antiox11010113. Antioxidants (Basel). 2022. PMID: 35052617 Free PMC article.
46 results